Alzheimer’s disease is a common form of dementia that affects memory and cognitive function. Recently, NAD+ (Nicotinamide Adenine Dinucleotide) – an important coenzyme in energy maintenance and cell function – has attracted attention in Alzheimer’s research. A decline in NAD+ levels is thought to be linked to neurodegeneration, opening up the potential for new therapies.